Filing Details

Accession Number:
0001225208-18-002314
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-08 16:14:55
Reporting Period:
2018-02-07
Accepted Time:
2018-02-08 16:14:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885725 Boston Scientific Corp BSX Surgical & Medical Instruments & Apparatus (3841) 042695240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1484186 Michael Joseph Fitzgerald 300 Boston Scientific Way
Marlborough MA 01752-1234
Evp & President, Rhythm Mgmt No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-07 85,227 $12.52 237,152 No 4 M Direct
Common Stock Disposition 2018-02-07 85,227 $26.48 151,925 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-02-07 85,227 $0.00 85,227 $12.52
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-02-12 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 77,323 Indirect By 401(k)
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
  2. Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
  3. Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $26.39 to $26.57, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  4. Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
  5. Grant to the reporting person of an option to purchase 85,227 shares of common stock vesting in four annual increments beginning on February 12, 2009, the first anniversary of the grant.